IP Library › Granted Patent US 10,881,776
Granted Patent B2
US 10,881,776 · App. 16/314,643 · Granted Jan 5, 2021

Control unit for detecting blood in a dialysate discharge line of a blood treatment device, and blood treatment device

Inventor: Alfred Gagel (Litzendorf, DE)
Assignee: FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH
A61M1/1692A61M1/165A61M1/1635A61M1/3413A61M1/3431A61M2205/15A61M2205/705
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,881,776
App. No.
16/314,643
Granted
Jan 5, 2021
Kind
B2
Abstract

The invention relates to a control unit ( 30 ) for detecting an overshoot of a first limit value (G 1 ) of a first blood concentration (B 1 ) in a first portion ( 17 a ) of a dialysate discharge line ( 17 ) downstream of a dialysate chamber ( 7 ) of a dialyser ( 4 ) of a blood treatment device and upstream of a node point ( 110 ) at which a bypass line ( 100 ) bypassing the dialyser ( 4 ) leads into the dialysate discharge line ( 17 ), wherein the bypass line ( 100 ) branches off, upstream of the dialysate chamber ( 7 ), from a dialysate supply line ( 15 ) suitable for supplying dialysate from a dialysate source ( 16 ) to the dialysate chamber ( 7 ).

Claims (15)

1. A blood treatment device for extracorporeal blood treatment comprising

a dialyser having a dialysate chamber,

a dialysate discharge line,

a control unit for detecting an overshoot of a first limit value of a first blood concentration in a first portion of the dialysate discharge line downstream of the dialysate chamber and upstream of

a node point at which

a bypass line bypassing the dialyser leads into the dialysate discharge line, wherein the bypass line branches off at a branch point, upstream of the dialysate chamber, from

a dialysate supply line for supplying dialysate from a dialysate source to the dialysate chamber,

a blood leak detector provided in a second portion of the dialysate discharge line downstream of the node point for measuring a second blood concentration in the second portion downstream of the node point, and in the absence of a blood leak detector in the first portion of the dialysate discharge line,

wherein the control unit detects an overshoot of a second limit value of the second blood concentration, wherein the second limit value decreases with rising flow rate in the dialysate supply line before the branch point of the bypass line, and wherein the control unit is configured, in the event of bypass operation, in which case dialysate is guided from the dialysate source via the dialysate supply line, the bypass line, and the second portion of the dialysate discharge line to an outflow, to consider the first limit value as having been overshot when the second blood concentration exceeds a third limit value, which is lower than the second limit value at the flow rate, and wherein the control unit is configured to trigger an alarm and/or to stop a blood pump when the second blood concentration exceeds the third limit value.

2. The blood treatment device according to claim 1 , characterised in that the control unit is configured in such a way that the third limit value is independent of the flow rate.

3. The blood treatment device according to claim 1 , characterised in that the control unit is configured in such a way that the third limit value is a constant.

4. The blood treatment device according to claim 1 , characterised in that the control unit is configured in such a way that in bypass operation a substitution rate of a pre-dilution is lower than a substitution limit value.

5. The blood treatment device according to claim 1 , characterised in that the control unit is configured in such a way that in bypass operation a dialysate flow through the dialyser is below a dialysate dialyser flow limit value.

6. The blood treatment device according to claim 1 , characterised in that the control unit is configured in such a way that the flow rate is predefined by a pump device in the dialysate supply line.

7. The blood treatment device according to claim 1 , characterised in that the control unit is configured in such a way that the flow rate is predefined by a balancing device.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 5, 2019
From: GAGEL, ALFRED
To: FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH
Reel/Frame 048505/0881 →
Priority Claims (1)
DE 10 2016 007 828 · Jun 29, 2016 · national
Continuity (1)
Related Publication 20190255241A1 · Aug 22, 2019